Evaluation of 'national drug strategies' in Europe
Introduction
Many countries have recently adopted a ‘national drugs strategy’. This Selected issue focuses on plans for the evaluation of these strategies, which for the first time has been enabled on a European scale by work undertaken by the national focal points. This work has helped to clarify references to evaluation in ‘national drugs strategies’, which are not always self-explanatory or clear-cut.
Table of contents
- Approaches to measuring national drugs strategies
- Evaluations: ‘ex ante’, ‘mid-term’ and ‘ex post’
- Actors in the evaluation
- Targets and indicators
- Efficiency
- Constraints on evaluation